ADMA vs ANAB Stock Comparison
ADMA currently leads ANAB in this stock comparison, with AIQ scores of 78 vs 56. The clearest difference is momentum.
What is the main difference between ADMA and ANAB?
ADMA leads the current stock comparison as ADMA Biologics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
ADMA Biologics, Inc. vs AnaptysBio, Inc.
ADMA leads
ADMA leads by 22 AIQ points, primarily on Momentum and Risk Resilience, and the lead has widened from 16 points over 30 sessions. Wall Street currently favors ANAB on target upside.
Stable: 5 of 6 evidence groups support ADMA, its lead is widening, and its current signal state is conflicted.
ADMA Biologics, Inc.
AnaptysBio, Inc.
The Algovestiq AIQ Score currently favors ADMA over ANAB, 78 versus 56 as of Nov 15, 2026. ADMA's advantage is driven primarily by stronger momentum and risk resilience. ADMA also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors ANAB. 5 of 6 covered evidence groups favor ADMA today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. ADMA lead: Strengthening — the AIQ differential moved from 16 to 22 points over 30 sessions.
Compare ADMA Biologics, Inc. and AnaptysBio, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare ADMA and ANAB against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum91 vs 36ADMA +55
- Risk Resilience56 vs 46ADMA +10
- Value80 vs 74ADMA +6
- Quality72 vs 72Even
5 of 6 evidence groups favor ADMA. ADMA’s edge is concentrated in momentum and risk resilience.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
No factor moved materially.
New signals
- RSI Overbought — bearish, momentum, short horizon
Largest factor move: Value -3
New signals
- ADX Trend Strengthening — neutral, trend, medium horizon
- Distribution Pattern — bearish, volume, medium horizon (1.22x)
ADMA's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — ADMA and ANAB both carry a full feed there.
The central trade-off
ADMA (ADMA Biologics, Inc.): the stronger current systematic profile, led by momentum and risk resilience.
ANAB (AnaptysBio, Inc.): the counter-case, on analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
ADMAADMA on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
ADMAADMA on combined revenue and EPS growth.
Value
ADMAADMA on the peer-relative Value factor, by 6 points.
Momentum
ADMAADMA on the Momentum factor, by 55 points.
Lower downside
ADMAADMA on Risk Resilience, by 10 points.
Analyst upside
ANABANAB on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors ADMA, analyst targets favor ANAB. That disagreement is the most useful thing on this page.
| Measure | ADMA | ANAB | Note |
|---|---|---|---|
| Implied upside to target | +31.6% | +75.1% | ANAB has more room |
| Target dispersion | 0% | +30.9% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 4 | 8 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
5 of 6 covered evidence groups favor ADMA. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | ADMA | 78 vs 56 |
| Fundamentals | ADMAon balance | revenue growth 13.4% vs 10.1%; EPS growth 29.4% vs -97.9%; TTM ROE 11.4% vs 18.6%; gross margin 68.5% vs 143.7%; operating margin 44.9% vs 34.6% — ADMA takes 3 of 5 decided legs, not all of them |
| Valuation | ADMA | Value 80 vs 74 |
| Technicals | ADMA | Price vs 50-day 29.4% vs -7.1%; vs 200-day 27.6% vs -18.1% |
| Risk Resilience | ADMA | Risk Resilience 56 vs 46 |
| Analyst expectations | ANAB | Target upside 31.6% vs 75.1% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ADMA and ANAB and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 22 points. (supports the conclusion holding)
- 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ADMA.
How the comparison changed
120 daily snapshots · May 27 – Nov 13ADMA lead: Strengthening — the AIQ differential moved from 16 to 22 points over 30 sessions.
- Today
- ADMA +22
- 78 vs 56
- 7 sessions ago
- ADMA +20
- 77 vs 57
- 30 sessions ago
- ADMA +16
- 69 vs 53
- 90 sessions ago
- ANAB +3
- 56 vs 59
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 2 bearish / 2 neutral, conflicted
Only ADMA
- Keltner Channel Breakout — bullish, volatility, short horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- RSI Overbought — bearish, momentum, short horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
0 bullish / 3 bearish / 2 neutral
Only ANAB
- Distribution Pattern — bearish, volume, medium horizon (1.22x)
- Downtrend Structure Active — bearish, trend, long horizon
Both carry 3 more signals that do not separate them: Death Cross Active, ADX Trend Strengthening, ATR Expansion - Breakout Mode.
ADMA leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +3.32%, AIQ 0 points).
Price and the AIQ Score both moved down over the latest session (price -3.18%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1ANAB closes the Momentum gap — currently 55 points behind, the largest single contributor to ADMA's edge.
- 2ANAB's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3ADMA's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
ADMA leads on balance| Metric | ADMA | ANAB |
|---|---|---|
| Revenue growth (YoY) | 13.4% | 10.1% |
| EPS growth (YoY) | 29.4% | -97.9% |
| Gross margin | 68.5% | 143.7% |
| Operating margin | 44.9% | 34.6% |
| Return on equity (TTM) | 11.4% | 18.6% |
| Debt to equity | 0.46 | 0.6 |
Performance
ADMA leads 4 of 6 windows| Metric | ADMA | ANAB |
|---|---|---|
| 1 week (5 sessions) | 7.5% | -0.4% |
| 1 month (20 sessions) | 28.1% | -0.8% |
| 3 months (63 sessions) | 46.5% | -22.5% |
| 6 months (126 sessions) | 65.4% | -26.8% |
| Year to date | -25% | -4.6% |
| 1 year (252 sessions) | -16.9% | 39.8% |
Technicals
ADMA has the stronger structure| Metric | ADMA | ANAB |
|---|---|---|
| RSI (14) | 71 | 42.7 |
| ADX (14) | 34 | 23.7 |
| Price vs 50-day | 29.4% | -7.1% |
| Price vs 200-day | 27.6% | -18.1% |
| Volatility (1M, annualized) | 102.3% | 51.8% |
Risk
ADMA is the more resilient| Metric | ADMA | ANAB |
|---|---|---|
| Beta | -0.09 | 1.11 |
| Sharpe ratio | -0.01 | 0.78 |
| Sortino ratio | -0.01 | 1.11 |
| Max drawdown | -62.7% | -35.3% |
| Current drawdown | -32.9% | -34.1% |
| Annualized volatility | 58.9% | 64.8% |
| Value at risk (95%) | -4.3% | -5.3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, ADMA or ANAB?
On the Algovestiq AIQ Score, ADMA is the stronger of the two as of Nov 15, 2026, scoring 78 against ANAB's 56. The edge comes from momentum and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is ADMA or ANAB the better buy right now?
ADMA carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 5 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor ADMA over ANAB?
The composite weights Quality, Value, Momentum and Risk Resilience. ADMA leads Momentum by 55 points; ADMA leads Risk Resilience by 10 points; ADMA leads Value by 6 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, ADMA or ANAB?
Analyst price targets imply +31.6% upside for ADMA and +75.1% for ANAB, so the Street currently favors ANAB. That points the opposite way to the AIQ Score, which favors ADMA. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, ADMA or ANAB?
ADMA is the better-valued of the two on the peer-relative Value factor. ADMA on the peer-relative Value factor, by 6 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, ADMA or ANAB?
ADMA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, ADMA or ANAB?
ADMA on the Momentum factor, by 55 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, ADMA or ANAB?
ADMA is the more resilient of the two, so the other name carries the higher downside risk. ADMA on Risk Resilience, by 10 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is ADMA more profitable than ANAB?
The profitability evidence is mixed: gross margin 68.5% vs 143.7%; operating margin 44.9% vs 34.6%; ttm roe 11.4% vs 18.6%. ADMA leads on one measure and ANAB on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is ADMA's lead over ANAB getting stronger or weaker?
ADMA lead: Strengthening — the AIQ differential moved from 16 to 22 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the ADMA vs ANAB verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ANAB closes the Momentum gap — currently 55 points behind, the largest single contributor to ADMA's edge; ANAB's Death Cross Active resolves — a bearish trend rule currently active against it; ADMA's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about ADMA and ANAB?
ADMA: 3 bullish / 2 bearish / 2 neutral, conflicted. ANAB: 0 bullish / 3 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ADMA is Death Cross Active (bearish, long horizon). On ANAB it is Death Cross Active (bearish, long horizon).
Compare ADMA and ANAB with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.